Thyroid C-mobile Tumors: In rodent studies, semaglutide is proven to lead to thyroid C-mobile tumors. It is actually mysterious whether this hazard applies to people, but semaglutide is contraindicated in clients with a personal or household historical past of medullary thyroid carcinoma (MTC) or clients with Many Endocrine Neoplasia syndrome style